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Summary Hepatocellular carcinoma (HCC) is one of the most common and rapidly fatal malignancies worldwide. Treatment options are
severely limited bythe frequent presence of metastases. If hepatocyte-specific mRNAs are detected in the circulation, it is possible to inferthe
presence of circulating, presumably malignant, liver cells. If these can be quantified, it is possible to predict the likelihood of haematogenous
metastasis. In this investigation, we have attempted to gain an index of the mass of circulating HCC cells (with reference to the number of
hepatoblastoma cells) by measuring the amounts of PCR products for albumin (alb) mRNA and a-fetoprotein (afp) mRNA by reverse
transcriptase polymerase chain reaction (RT-PCR) and Southern blot analysis. Forcalibration, total RNA from 1-106 HepG2 cells was mixed
with total RNA from 106 normal peripheral mononuclear cells. A linear relationship was demonstrated between the amount of a/b- or afp PCR
product and the level of HepG2 total RNA spiked. The assay is sensitive down to a detection level of one HepG2 cell. AlbmRNA was detected
in 50% of 18 normal subjects and afp mRNA in only two normal subjects. The alb mRNA cut-off level for the normal was exceeded by seven
normal subjects and 34 out of 64 HCC patients, and that for afp mRNA was exceeded by six HCC patients but none of the normal subjects.
The level of alb mRNA detected was not linearly proportional to the amount of afp mRNA detected in peripheral blood of the same patients,
suggesting heterogeneous expression of alb and afp genes in different circulating tumour cells. In addition, no significant linear association
between the levels of afp mRNA and serum AFP was observed. Semiquantification of both mRNA markers for HCC cell detection may prove
useful in prediction of metastases.
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The only hope of long-term survival for patients with hepato-
cellular carcinoma (HCC) is surgical resection or livertransplanta-
tion. However, these options are frequently limitedby the presence
of intrahepatic and/or extrahepatic metastases. Recurrence of
micrometastases may develop following surgical intervention,
which is reported in a number oftumour types to produce tumour
cell shedding. Detection of metastasis at an early stage might
permit a more appropriate choice ofpatients for surgery and could
be valuable in monitoring their response to chemotherapy, radio-
therapy, resection or transplantation.
Recently, it has been proposed that it is possible to infer the
presence of circulating HCC cells, and hence the potential for
metastasis formation, if mRNAs of hepatocyte-specific albumin
(alb) and a-fetoprotein (afp) genes are detected in peripheral
blood by reverse transcriptase polymerase chain reaction (RT-
PCR). Indeed, there is evidence that detection of alb mRNA and
afp mRNA is strongly associated with the presence of metastases
(Hillaire et al, 1994; Matsumura et al, 1994; Kar and Carr, 1995;
Komeda et al, 1995; Nambu et al, 1995). An analogous approach
has been applied in patients with breast cancer, neuroblastoma,
melanoma and colon cancerusing mRNAs ofcytokeratin 19, tyro-
sine hydroxylase, tyrosinase and carcinoembryonic antigen as
markers respectively (Naito et al, 1991; Burchill et al, 1994; Datta
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et al, 1994; Gerhard et al, 1994). On the basis of such studies, it
appears that the RT-PCR assay is sufficiently sensitive to detect
1-100 tissue-specific cells among 106 peripheral blood mono-
nuclear cells (PMNCs).
Nevertheless, the specificity of the RT-PCR test has been
brought into question as alb mRNA was detected in peripheral
blood of many normal subjects and afp mRNA was identified in
peripheral blood of patients with chronic hepatitis or cirrhosis
(Matsumura et al, 1994; Nambu et al, 1995). This phenomenon,
attributed to 'illegitimate transcription', was also noticed when
mRNAs of P-glycoprotein (P-Gp) 9.5, tyrosinase, cytokeratin 18
and 19, and epithelial membrane antigen were used as markers for
other tumours (Mattano et al, 1992; Naito et al, 1991; Burchill et
al, 1994, 1995). In this study, wehave attempted to develop a semi-
quantitative estimation of the amounts of 'hepatocyte-specific'
mRNAs in the circulation ofnormal subjects and HCC patients for
differential detection of HCC cells rather than normal PMNCs.
Also, the mass ofcirculating HCC cells in HCC patients was esti-
mated with reference to the number of hepatoblastoma cells
(HepG2). In addition, the correlation between the levels of alb
mRNA and afp mRNA in the same patients was studied, as was the
association between the amounts ofa,fp mRNA and serum AFP.
MATERIALS AND METHODS
Whole blood samples from 18 normal subjects and 64 HCC
patients were collected. The HCC patients all had either histolog-
ical confirmation of the diagnosis or the combination of a hepatic
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Table 1 Sequences of PCR primers
Primer Sequences
P2-Microglobulin 1 5'-CCT GM TTG CTATGT GTC TGG GTT TCATCC A-3'
P2-Microglobulin 2 5'-GGA GCA ACC TGC TCA GAT ACATCAMC ATG G-3'
Albumin 1 5'-TGC TTG MT GTG CTG ATG ACA GGG 3'
Albumin 2 5'-MG GCA AGT CAG CAG GCA TCT CAT C-3'
Albumin P 5'-CAC AGC ATT CCTTCA GTTTAC TGG AGATCG-3'
a-Fetoprotein 1 5'-TGC AGC CM AGT GM GAG GGA AGA-3'
a-Fetoprotein 2 5'-CAT AGC GAG CAG CCC MA GM GM-3'
a-Fetoprotein P 5'-CAG CAT CGA TCC CAC TH TCC MG TTC CAG-3'
mass detected by an imaging procedure and a raised serum AFP
level in a setting ofchronic liver disease.
Peripheral mononuclear cell isolation and RNA
extraction
Peripheral mononuclear cells (PMNCs) were isolated from 20 ml of
citratedbloodcollected fromnormal subjects orHCCpatients using
Ficoll-Paque plus (Pharmacia). The cells were washed with 30 ml
of phosphate-buffered saline (PBS). After centrifugation at 100 g
for 10 min, the cell pellet was resuspended in 1 ml ofPBS and the
PMNC number was counted in ahaemocytometer. Aftercentrifuga-
tion, the cell pellet was resuspended in 0.5 ml ofguanidinium thio-
cyanate solution (4M guanidinium thiocyanate, 0.5% Sarkosyl,
25 mm sodium citrate (pH 7) and 0.1 M 2-mercaptoethanol) and
frozen at -70°C for temporary storage. Total RNA was extracted
by a single-step method (Chomczynski and Sacchi, 1987).
Cell culture
The hepatoblastoma cell line HepG2 (Aden et al, 1979; Knowles et
al, 1980) was used to establish acalibration assay for assessment of
the amounts of mRNA markers. The cell line was cultivated in
RPMI medium (Gibco, BRL) to which was added Hepes, gluta-
mine, penicillin and streptomycin, and supplemented with 10%
fetal bovine serum (Gibco, BRL). The medium was changed every
3 days and the cells were harvested when the growth was subcon-
fluent. The total cell number was counted in a haemocytometer.
Table 2 Numbers of circulating HCC cells in blood samples (20 ml) from 17
HCC patients
Patient no. Estimated cell number
P1 1273
P15 13
P16 > 100 000
P18 5139
P20 36 061
P26 > 100 000
P30 > 100 000
P33 31
P37 > 100 000
P39 23 837
P40 6762
P57 > 100 000
P59 4514
P60 37 255
P61 > 100 000
P62 9
P64 34
The numbers of circulating HCC cells were estimated with reference to the
number of HepG2 cells, based on the amount of alb mRNA or afp mRNA
detected above the upper limit of the reference range. If both mRNAs were
detected at levels above the upper limit, the number of circulating HCC cells
was estimated from the level of afp mRNA.
Spiking experiments
To simulate the presence of HCC cells in the circulation of HCC
patients, total RNA was extracted from PMNCs in 20 ml ofperiph-
eral blood of a normal subject and 107 HepG2 cells respectively.
Aliquots of total RNA derived from 106 normal PMNCs were
mixed with HepG2 total RNA, corresponding to 1, 10, 102, 103,
104, 105 and 106 HepG2 cells respectively, based on the calculation
ofthe average amount ofHepG2 total RNA extracted per cell.
RT-PCR and semiquantitative Southern blot analysis
Total RNA (0.5 or 1 jig) was denatured at 65°C for 2 min and
annealed with 1 jig of random primers at 37'C for 10 min. A
reverse transcription reaction contained 0.5 gl ofRNAase block II
(Stratagene), 1 x RT buffer (50 mv Tris-HCl (pH 8.3), 75 m M
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Figure 1 Measurement of alb mRNA signals by semi quantitative RT-PCR. Total RNA extracted from 106 normal PMNCs was spiked with total RNA of a
certain number of HepG2 cells (0, 100, 101, 102, 103, 104, 105, 106), as shown in lanes C, 0, 1, 2, 3, 4, 5 and 6 respectively (right). The bottom of autoradiograph
shows the quantities of HepG2 total RNA used for the RT-PCR assay. The relationship between the volume of the alb PCR product measured by densitometry
and the amount of HepG2 total RNA spiked (on logarithmic scales) was found to be linear in a 106-fold range equivalent to 1-106 cells. The equation of the
linear regression is y = 0.1 525x + 0.4023 and the square of the correlation coefficient is equal to 0.9148
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potassium chloride, 3 mm magnesium chloride), 10 mm DTT,
0.5 mm dNTPs and 200 U of Moloney murine leukaemia virus
reverse transcriptase (Gibco, BRL). CDNAs were synthesized at
37°C for 1 h and the reaction was stopped at 70°C for 7 min. PCR
amplification of the two markers, alb- and afp cDNAs, was
conducted using gene-specific primers (Table 1) that lie within
different exons to give PCR products of 157 bp and 215 bp respec-
tively. [B2-Microglobulin mRNA served as an internal control to
ensure that a similar amount of high-integrity total RNA was
reverse transcribed to produce cDNAs in each assay. The PCR
reaction of 50 ,l contained 1 x PCR buffer [20 mm Tris-HCl
(pH 8.4), 50 mm potassium chloride, 2.5 mm magnesium chlo-
ride], 0.2 mM dNTPs, 30 pmol forward and reverse primers ofP2-
microglobulin and the marker gene, 3 gl of cDNA products and
2.5 U of Taq DNA polymerase (Gibco, BRL). The cycle profile
included denaturation at 94°C for 5 min, 30 cycles of 940C for
1 min, 61°C for 1 min and 720C for 1 min and a final extension at
72°C for 10 min.
The gene specificities of the PCR products were verified by
non-radioactive Southern blot analysis using digoxigenin-3'-
end labelled gene-specific oligonucleotides (albumin P or a-
fetoprotein P, Table 1) followed by chemiluminescent detection
with CSPD (disodium 3-(4-methocyspiro{ 1,2-dioxetane-3,2"-(5"-
chloro) tricyclo[3.3.1.137] decan}-4-yl) phenyl phosphate (Boeh-
ringer Mannheim). The volumes of the bands were analysed and
quantified by imaging densitometry (model GS-700, BioRad).
RESULTS
Linear calibration curves for semiquantification
In the spiking experiment, the band volumes of alb and afp PCR
products increased with the amountofHepG2 total RNA spiked into
total RNA ofnormal PMNCs. The relationship between the amount
ofalb PCR product and the level of HepG2 total RNA spiked was
found to be linear on logarithmic scales, in a 106 fold range of 1.65-
1 650 000 pg total RNA (or 1-106 HepG2 cells) (Figure 1) and that
between the amountofaffi PCRproductandthelevel ofHepG2 total
RNA was linear in a 106-fold range of 165-1 650 000 pg total RNA
Table 3 Levels of afp mRNA and serum AFP in 13 HCC patients
afp mRNA levels Serum AFP levels
Patient no. [HepG2 total RNA (pg)] (ng ml-1)
P1 2100.92 494 300
P12 < 10 < 10
P15 21.81 45 660
P30 < 10 23 760
P33 51.46 44 890
P35 < 10 248
P44 < 10 13 340
P49 < 10 3372
P51 < 10 26 485
P54 < 10 < 10
P57 4 276 022 < 10
P62 15.58 2
P64 56.26 14
(Figure 2). From the calibration curves, the number of circulating
HCC cells in patients' blood samples could be estimated with refer-
ence to the numberofHepG2 cells, based on the amounts ofalb and
ajf mRNAs detected in peripheral blood. Our data suggest that this
semiquantitative RT-PCR assay is sensitive down to adetection level
ofone HepG2 cell among a total of 106 cells.
Albumin mRNA in normal subjects and HCC patients
An alb mRNA signal was detected in peripheral blood of 9 out of
18 (50%) normal subjects and 44 out of 64 (69%) HCC patients.
The alb mRNA level that permitted the best discrimination
between the normal and HCC subjects was determined to be 1 pg
of HepG2 total RNA, which is below the limit of detection. This
value, arbitrarily deemed the 'optimal cut-off' ofthe normal refer-
ence range, was exceeded in seven normal subjects and 34 HCC
patients (Figure 3). The mean alb mRNA level among the normal
group (n = 18) was equivalent to 0.51 ng ofHepG2 total RNA per
20 ml of peripheral blood with a corresponding mean level of
3778.19 ng in the HCC group (n = 64) (P < 0.05, Mann-Whitney
U-Wilcoxon rank sum W-test).
1.6 T
S
E
1.4
.2
.1.0~
-Q..8
OA
0A2
n.'..d,'ssv
',.. .' /
...
.. ..
:^ r
.. , ,is.'*:,--'-
- ;* - %= c .{ "; . ; s
S - ;;' ;'. t*' ts.' '
:, *. .t
._ ..
,;
,. i. r.
.. HepG2
.t. '.. ANA Inni
.0 2 . 4 6 8
Legtota ANA
Figure 2 Measurement of afp mRNA signals by semi quantitative RT-PCR. Total RNA extracted from 106 normal PMNCs was spiked with total RNA of a
certain number of HepG2 cells (102, 103, 104, 105 or 106), as shown in lanes 2, 3 4, 5 and 6 respectively (right). The bottom of the autoradiograph shows the
quantities of HepG2 total RNA used for the RT-PCR assay. The relationship between the volume of the afp PCR product measured by densitometry and the
amount of HepG2 total RNA spiked (on logarithmic scales) was found to be linear in a 104-fold range equivalent to 102-106 cells. The equation of the linear
regression is y = 0.1819x+ 0.3121 and the square of the correlation coefficient is equal to 0.9077.
British Joumal ofCancer(1997) 76(5), 628-633
.,
0 CancerResearch Campaign 1997Semiquantification ofcirculating HCC cells 631
10 000 000
1 000 000 0001
100 000 000
10 000 000-
1 000 000-
100 000.
10 000
alb upper limit
1000.
100.
10.
alb optimal cut-off 1.
a
U.
U.
.
HOC Patients
A
A
A'A
A
A
A
Normal
Figure 3 Alb mRNA levels equivalent to HepG2 total RNA (pg) (on
logarithmic scales) in peripheral blood (20 ml) from normal subjects (A) and
HCC patients (U). The levels were calculated according to the calibration
curve of the volume of the alb PCR product against HepG2 total RNA on
logarithmic scales. The optimal alb mRNA cut-off point and the upper limit of
the reference range for the normal group are indcated
Alpha-fetoprotein mRNA in normal subjects and HCC
patients
In contrast, there was almost no overlap in the afp mRNA levels
between the normal and HCC groups. An afp mRNA signal was
detected in only 2 out of 18 normal subjects compared with 13 out
of64 HCC patients. The level ofafp mRNA that permitted the best
discrimination between the normal and HCC subjects was deter-
mined to be 10 pg of HepG2 total RNA, which is below the limit
ofdetection. This value, arbitrarily deemed the 'upper limit' ofthe
normal reference range, was exceeded in six HCC patients but
none ofthe normal subjects (Figure 4). The mean afp mRNA level
among the normal subjects (n = 18) was equivalent to 0.219 pg of
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Figure 4 Afp mRNA levels equivalent to HepG2 total RNA (pg) (on
logarithmic scales) in peripheral blood (20 ml) from normal subjects (A) and
HCC patients (*) (A represents one patient and represents ten patients).
The levels were calculated according to the calibration curve of the volume of
the afp PCR product against HepG2 total RNA on logarithmic scales. The
upper limit of the afp mRNA reference range for the normal group is indicated
HepG2 total RNA per 20 ml of peripheral blood compared with
66 847.94 pg in the HCC group (n = 64) (P < 0.19, Mann-Whitney
U-Wilcoxon rank sum W-test).
Semiquantification of circulating HCC cells in HCC
patients
The HepG2 RNA standards corresponding to 1 (1.65 pg), 10
(16.5 pg), 102 (165 pg), 103 (1650 pg), 104 (16.5 ng), l0s (165 ng)
and 106 (1.65 gg) HepG2 cells were included in each Southern
B
Normal Patients Standards
I 1
lkb Ni N2 N3 N4 P1 P2 P3 P4 1000 10000
- bm
alb
- bm
- afp
Figure 5 Detection of a/b- (A) and afp mRNAs (B) by RT-PCR in peripheral blood from normal subjects (Ni, N2, N3 and N4) and HOC patients (P1, P2, P3
and P4) on ethidium bromide-stained 2% agarose gel. Beta-2-microglobulin mRNA served as an internal control and 1 kb ladder (1 kb) is shown. An
approximately equal amount of beta-2-microglobulin mRNA was reverse transcribed and its cDNA was co-amplified with the marker to give a 441 bp product in
each lane. HepG2 RNA standards corresponding to 100 to 104 HepG2 cells were included as positive controls
British Journal ofCancer (1997) 76(5), 628-633
a
z CC 0
Fo
N
CL4 0~
a)
I
0
C cr
a)
CD, al)
a)
z cc
E
.CancerResearch Campaign 1997632 I H-N Wong etal
A
Normal Patients Standards
I II 1 1
Ni N2 N3 N4 P1 P2 P3 P4 100 1000
B
Normal Patients Standards
Ni N2 N3 N4 P1 P2 P3 P4 100010000
- alb _afp
Figure 6 Semi quantification of alb- (A) and afp PCR products (B) by Southern blot analysis. Ni, N2, N3 and N4 represent normal subjects and P1, P2, P3
and P4 represent HCC patients. HepG2 RNA standards corresponding to 100 to 104 cells were included in the Southern blot analysis as reference standards
blot analysis as concentration standards. The amounts of alb and
afp mRNAs detected in 20 ml of peripheral blood from HCC
patients above the normal reference range would indicate the
number of HCC cells spread into the circulation with reference to
HepG2 as a standard (Table 2). For example, 1273 circulating
HCC cells were inferred in patient P1, in whom both afp and alb
mRNA signals were detected above the normal reference range in
peripheral blood (Figures 5 and 6) and who developed lung metas-
tasis 2 months after the RT-PCR diagnosis.
Association between albumin mRNA, alpha-fetoprotein
mRNA and serum AFP
In this investigation, the amount of alb mRNA detected was not
linearly proportional to the level of afp mRNA detected (on
logarithmic scales) in peripheral blood of the 36 HCC patients
who were positive for alb mRNA and/or afp mRNA (r = -0.27,
P < 0.06, Pearson correlation). In addition, there was no significant
association between the levels of aft mRNA and serum AFP (on
logarithmic scales) among the 13 HCC patients tested positive for
aft mRNA (r = -0.13, P < 0.34, Pearson correlation; Table 3).
DISCUSSION
Our semiquantitative RT-PCR technique is a sensitive assay that
confirms the gene specificities ofthe PCRproducts, and can detect
a single HepG2 cell among 106 PMNCs. This technique is of
similar sensitivity to the nested RT-PCR method, as,described
previously (Matsumura et al, 1995). It has been reasoned that, as
the alb gene is specifically transcribed in liver cells, any alb-
expressing cells detected in peripheral blood should be abnormal
and, presumably, are HCC cells (Hillaire et al, 1994; Kar and Carr,
1995). Kar and Carr (1995) reported that alb mRNA was not
detected in peripheal blood of six normal subjects by RT-PCR.
However, Matsumura et al (1995) demonstrated the presence of
alb mRNA in all 26 normal subjects by a more sensitive nested
RT-PCR assay. In this investigation, intermediate results were
shown with positive signals ofalb mRNA detected in 9 out of 18
(50%) normal subjects. This clearly suggests that the frequency of
alb mRNA detection depends on the sensitivity of the assay used
and the quantitative assays need to be optimized fordiscrimination
between normal and malignant cells.
We cannot rule out the possibility that alb mRNA detected in
peripheral blood of the normal subjects is derived from normal
circulating hepatocytes. However, it is more reasonable to consider
this as illegitimate transcription of alb gene at different levels in
PMNCs (Chelly et al, 1989). In fact, alb mRNA has been detected
in organs such as testis, uterus, placenta and yolk sac as well as the
liver in rats (McLeod et al, 1989). To determine the extent to which
the levels of alb mRNA indicate any subsequent metastases, the
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clinical outcomes of the high-risk HCC patients with significantly
high alb mRNA levels detected are being followed up closely. It is
noteworthy that there is an overlap in alb mRNA levels between
normal and HCC subjects. The alb optimal cut-off level was
exceeded in seven normal subjects and 34 HCC patients. Among
the 34 HCC patients, 11 patients had alb mRNA levels higher than
the upper limit of the normal reference range. Three of these 11
patients demonstrated alb mRNA levels more than 1000-fold
higher than the upper limit. These grossly raised alb mRNA levels
presumably represent genuine detection ofcirculating HCC cells.
The mass ofcirculating malignant HCC cells was estimated only
with reference to HepG2 cells, which serve, in turn, as a reference
for comparison between the normal and HCC subjects. Clearly, the
presence ofalb mRNA inperipheral blood does notalways indicate
circulating HCC cells, as it is readily detected in some normal
subjects. This emphasizes the importance of developing a semi-
quantitative RT-PCR assay for differentiation between normal and
HCC subjects. Further, the lack of any direct correlation between
the levels ofalb- and aft, mRNA implies that there could be consid-
erable heterogeneity in the expression ofalb and aftu genes among
different HCC cells. We suspect that, as the aftp gene is only very
weakly expressed in normal adult hepatocytes (Tamaoki and
Fausto, 1984), the level ofafp mRNA detected in peripheral blood
of HCC patients may provide a closer approximation to the true
number of malignant HCC cells than does the amount of alb
mRNA. To improve our semiquantificative analysis, we are
currently applying patients' tumour and normal liver tissues to set
up 'patient-specific' calibration curves for quantitation.
It is unlikely that alb mRNA and aft mRNA detected in periph-
eral blood by RT-PCR are derived from lysedhepatocytes (Kar and
Carr, 1995; Komeda et al, 1995) as free mRNAs from
cytolysis are readily degraded by RNAases in the circulation.
Some atypical cells with large nuclei were noticed in the smeared
peripheral blood of a patient who was tested positive for afp
mRNA (Komeda et al, 1995). Although these cells may represent
putative circulating HCC cells, theirpotential for leading to devel-
opment of metastases is still unknown. It is well established that
only a small percentage of circulating HCC cells with malignant
potential can survive in the circulation and ultimately cause metas-
tasis, and a certain minimal tumour cell burden appears to be
essential for metastasis formation (Liotta et al, 1974). Therefore,
semiquantification of circulating HCC cells may be potentially
useful forprediction ofthe development ofmetastasis.
It is well documented that the level ofaft transcription and the
amounts of AFP synthesis and secretion may vary among HCC
cells in liver tumours ofdifferent HCC patients (Di Bisceglie et al,
1986). This is in agreement with the observation that HCC patients
exhibit a wide range of serum AFP levels. Generally, the levels of
aft mRNA in HCC sections of liver tumour tissue parallel the
amount of serum AFP in the patient (Belanger et al, 1983; Otsuru
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et al, 1988). However, strong afp mRNA signals have been
detected even in tumours obtained from patients with low serum
AFP levels (Di Bisceglie et al, 1986). Nambu et al (1995) have
demonstrated, in their preliminary studies, an afp mRNA signal in
peripheral blood of HCC patients with serum AFP levels of
< 20 ng ml-' but no such signal in HCC patients with serum AFP
levels of> 400 ng ml-'. In the present study, the intensity ofthe afp
mRNA signal detected in peripheral blood was not linearly
proportional to the level of serum AFP. For instance, a very high
level of afp mRNA was shown in patient P57 with a serum AFP
level of < 10 ng ml-', whereas only minimal levels of afp mRNA
were detected in patients P30, P44 and P51 with very high serum
AFP levels (Table 3). Thus, it appears that serum AFP levels are
unrelated to the risk of metastasis, whereas ak mRNA detected in
peripheral blood may be a more reliable marker for quantitation of
circulating HCC cells and prediction ofmetastasis formation.
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